MEDIUM confidence
Researched 2026-07-24 07:41 · profile: researcher
Programme Thesis
The DayOne Accelerator Program for Healthtech funds early-stage healthtech startups to accelerate their growth through mentorship, networking, and investor access. It exists to bridge the gap between innovative health solutions and market adoption, particularly in the EU ecosystem.
Selection Criteria
- Innovation and scientific validity of the healthtech solution
- Market potential and scalability within the health sector
- Strength and expertise of the founding team
- Traction or validation (e.g., pilot data, patents, endorsements)
- Clear business model and financial projections
- Fit with accelerator's focus on digital health, medtech, or biopharma
Past Winners / Cohort Profiles
Past cohorts typically include early-stage healthtech startups with digital health platforms, AI diagnostics, or medical devices. Examples are not listed on the page, but archetypes include teams with clinical validation, a working MVP, and a clear go-to-market strategy in EU healthcare.
Ideal Candidate Fingerprint
A healthtech startup with a validated AI or biotech platform addressing a critical healthcare challenge, led by a team with domain expertise and business acumen. The ideal applicant has early traction (e.g., pilot studies, patents, or endorsements from key opinion leaders) and a scalable model targeting EU or global markets.
Recommended Framing
Eniola should position his venture as a healthtech startup with a validated AI-driven platform (CCT model, IMPRINT, TOPOLOGIX) for addiction and drug resistance prediction, emphasizing the strong scientific endorsements from Berridge, Gershman, and Daw as proof of credibility. Highlight the provisional patent and pre-registered hypotheses as traction, and frame the Africa angle as a unique market insight for global health impact.
Watch Out
The programme targets EU-based startups, and Eniola is based in Nigeria with no EU entity yet; this may require a local partner or subsidiary. Also, the accelerator focuses on healthtech startups, not individual researchers, so Eniola must present as a startup founder with a clear business plan, not as an independent researcher.